2025 annual financial data
REGENXBIO 2025 Operating margin
REGENXBIO 2025 operating margin with verified reported values.
Direct answer
Operating margin was -94.58%.
Operating income was -161,198,000 USD and net income was -193,878,000 USD.
Operating cash flow was -123,963,000 USD.
Get free REGENXBIO email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 170,441,000 USD
- Operating income
- -161,198,000 USD
- Net income
- -193,878,000 USD
- Operating cash flow
- -123,963,000 USD